Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose antibiotics plus methenamine hippurate versus standard care for chronic urinary tract infection
ISRCTN17592593Phase 2Recruiting
- Sponsor
- University College London Comprehensive Clinical Trials Unit
- Start
- Feb 2026
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, open-label trial of cefalexin, nitrofurantoin, trimethoprim, methenamine hippurate and amoxicillin in urinary tract infection (UTI) (2 arms), sponsored by University College London Comprehensive Clinical Trials Unit. Started Feb 2026; status: recruiting.
02
Drugs
cefalexinnitrofurantointrimethoprimmethenamine hippurateamoxicillin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ISRCTN17592593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17592593.